Clinical Trial

To Evaluate the Safety, Pharmacokinetic and Pharmacodynamics of JW0061 in Healthy Volunteers

Recruiting Phase 1
View on ClinicalTrials.gov →
Summary
This clinical study is a phase 1, randomized, double-blind, placebo-controlled, dose escalation clinical trial to evaluate the safety, pharmacokinetic and pharmacodynamics of JW0061 following topical application in Korean and Caucasians healthy adults.
Protocol Amendment History 1 change
critical Recruitment opened 2026-04-24
Trial Details
NCT Number NCT07514780
Lead Sponsor JW Pharmaceutical
Conditions Healthy
Enrollment 104 participants
Start Date 2026-04-13
Primary Completion 2026-12-31 (estimated)
Study Completion 2027-04-30 (estimated)
Updated on ClinicalTrials.gov 2026-04-23